相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytomegalovirus quantification: Where to next in optimising patient management?
Claire Atkinson et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients
Tomas Reischig et al.
ANTIVIRAL THERAPY (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation
F. M. Mattes et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Polyfunctional Cytomegalovirus-Specific CD4+and pp65 CD8+T Cells Protect Against High-Level Replication After Liver Transplantation
G. Nebbia et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease
Corinna La Rosa et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
J. A. Khoury et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis
Roland R. Regoes et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir
FM Mattes et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Evolution of hepatitis B virus during primary infection in humans: Transient generation of cytotox T-cell mutants
SA Whalley et al.
GASTROENTEROLOGY (2004)
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease
A Humar et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts
VC Emery et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center
JK Preiksaitis et al.
TRANSFUSION (2002)
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation
C Jung et al.
TRANSPLANTATION PROCEEDINGS (2001)
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation
M Sester et al.
TRANSPLANTATION (2001)
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
AP Limaye et al.
LANCET (2000)
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
VC Emery et al.
LANCET (2000)
分享论文
